Precigen (PGEN) Acquisitions (2013 - 2018)

Precigen's (PGEN) quarterly Acquisitions came in at $920000.0 in Q4 2018, down 90.26% on a QoQ basis from $9.4 million in Q4 2015.

Precigen (PGEN) Acquisitions (2013 - 2018) Analysis & Trends

Precigen (PGEN) has 4 years of Acquisitions data on file, last reported at $920000.0 in Q4 2018.

On a quarterly basis, Acquisitions changed N/A year-over-year to $920000.0 in Q4 2018; TTM through Dec 2018 was $920000.0, a N/A change from a year earlier, with the FY2018 full-year figure at $920000.0, up 144.79% from the prior year.
Acquisitions for Q4 2018 stood at $920000.0, down from $9.4 million in the prior quarter.
Over the last five years, Acquisitions for PGEN reached as high as $75.0 million in Q3 2015 and fell as low as $460000.0 in Q4 2014.
Historically, Acquisitions has averaged $24.1 million across 3 years, with a median of $9.7 million in 2015.
Across the five-year window, Acquisitions soared 9300.0% in 2014 and gained 20.54% in 2015, its largest moves.
Year by year, Acquisitions stood at $460000.0 in 2014, then soared by 1953.91% to $9.4 million in 2015, then tumbled by 90.26% to $920000.0 in 2018.
Per Business Quant data, the three most recent Acquisitions figures were $920000.0 in Q4 2018, $9.4 million in Q4 2015, and $75.0 million in Q3 2015.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	Precigen	1.96 Bn	1.96 Bn	20.69 Mn	-

Download Data